BioCote reduces bacteria by 95% in hospitals

The antimicrobial technology firm BioCote Ltd, which is showing its products at the British Pavillion, is also promoting the results from the first study to investigate how silver antimicrobial products can reduce levels of bacteria in hospitals, clinics and care homes.

Biocote is at the ABHI UK Pavilion: Hall 16, stand F20-6
Biocote is at the ABHI UK Pavilion: Hall 16, stand F20-6

The environmental trial compared two out-patient units at the Heart of England NHS Foundation Trust. One facility was equipped with BioCote-protected furniture and equipment, for example sack holders, beds and curtains; the other contained standard, non-treated items.
There was a 95.8% reduction in bacteria in the environment containing the BioCote-protected products, compared to the control facility that had not been BioCote-protected. ‘The trial proves that using BioCote-protected products in a hospital environment can result in a reduction in bacteria, leading to a more hygienic and safer environment for patients,’ the manufacturer points out. ‘Fewer bacteria can reduce the risks of cross-contamination and consequently the risks of patients being infected with superbugs such as MRSA.’

21.11.2008

More on the subject:
Read all latest stories

Related articles

Photo

News • MRSA

Decolonization protocol can prevent dangerous infections

Antiseptic soap, mouthwash, and nose ointment after hospital discharge reduced infections and infection-associated hospitalizations due to MRSA in high-risk patients. Hospital patients who have…

Photo

News • Hospital hygiene

Will resistant bacteria be the end of alcohol hand sanitizers?

Alcohol-based hand sanitisers have been a mainstay in hospital hygiene for decades. But now, strains of antibiotic-resistant bacteria show signs of overcoming these handwashing agents as well. Does…

Photo

Article •

Study confirms universal decolonization of ICU patients

Patients' pathogen acquisition was reduced with Chlorhexidine gluconate 2% w/v impregnated pad, and intranasal mupirocin ointment - Study published in New England Journal of Medicine confirms…

Subscribe to Newsletter